Indo-Bangla Pharmaceuticals Limited (DSE:IBP)

DSE:IBP Cash Flow Statement

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Jun 30, 2024	Jun 30, 2023	Jul 1, 2022	Jul 1, 2021	Jun 30, 2020
Net Income	-44.98	-40.98	8.41	25.17	134.73	156.24
Depreciation & Amortization	26.14	28.54	38.36	39.13	35.9	28.9
Loss (Gain) From Sale of Assets	-	-	-0.7	-	0.77	-
Other Operating Activities	3.2	14.32	21.4	-1.54	7.69	25.11
Change in Accounts Receivable	21.39	21.39	-4.72	26.82	-19.67	-46.04
Change in Inventory	17.02	17.02	2.47	21.01	-11.8	12.58
Change in Accounts Payable	0.02	0.02	-0.09	0.31	0.25	-5.74
Change in Other Net Operating Assets	-6.55	-6.55	7.82	-23.61	3.17	4.47
Operating Cash Flow	16.25	33.77	72.95	87.28	151.02	175.53
Operating Cash Flow Growth	-79.96%	-53.71%	-16.42%	-42.20%	-13.96%	5.24%
Capital Expenditures	-5.57	-10.13	-30.03	-39.68	-200.41	-309
Investing Cash Flow	-5.57	-10.13	-43.47	-54.18	-200.41	-309
Short-Term Debt Issued	-	-	-	-	84.94	-
Total Debt Issued	2.82	-	-	-	84.94	-
Short-Term Debt Repaid	-	-19.41	-31.75	-9.59	-	-
Total Debt Repaid	-18.09	-19.41	-31.75	-9.59	-	-
Net Debt Issued (Repaid)	-15.27	-19.41	-31.75	-9.59	84.94	-
Common Dividends Paid	-0.29	-0.29	-10.4	-24.79	-26.91	-13.27
Other Financing Activities	-4.52	-4.85	-4.72	-5.63	-	-
Financing Cash Flow	-20.08	-24.55	-46.87	-40	58.03	-13.27
Miscellaneous Cash Flow Adjustments	0	-0	-	0	13.11	-
Net Cash Flow	-9.39	-0.91	-17.39	-6.9	21.75	-146.74
Free Cash Flow	10.68	23.64	42.92	47.6	-49.39	-133.47
Free Cash Flow Growth	-80.22%	-44.92%	-9.84%	-	-	-
Free Cash Flow Margin	8.97%	13.38%	11.46%	9.82%	-6.31%	-15.41%
Free Cash Flow Per Share	0.09	0.20	0.37	0.41	-0.43	-1.17
Cash Interest Paid	4.52	4.85	4.72	5.63	-	-
Cash Income Tax Paid	3.43	3.6	-	13.72	16.35	35.65
Levered Free Cash Flow	18.8	29.92	15.65	75.07	-74.57	-157.1
Unlevered Free Cash Flow	21.42	32.67	18.92	78.12	-72.19	-157.1
Change in Net Working Capital	-18.68	-29.11	7.34	-56.3	15.99	9.39

Updated Dec 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.